The Agriculture Improvement Act of 2018 — commonly referred to as the Farm Bill — authorized the production of hemp, kicking off a hotly contested debate about the health and safety of hemp and marijuana. This blog is part of an ongoing series of blogs following the activities by federal organizations to address regulatory issues […]
Author Archives: Pearl D'Cruz, Guest Blogger
Latest Blog Posts
10
Jul
Jul
The use of cannabis and cannabis-derived products, including hemp and hemp-derived products, has increased dramatically in recent years, and questions loom large about the health and safety of these products. In my May blog, I wrote about the quiet revolution occurring in the cannabis industry as agricultural opportunities intersect with the drug approval process. Recently, […]
03
May
May
Drug safety has always been my passion. My career over the last three decades has been shaped by growing up in an environment governed by evolving drug safety regulations. Whether it has involved reviewing spontaneously reported adverse events for approved drugs or adverse event reports from a clinical trial under an Investigational New Drug application, […]